May 14, 2020 / 1:28 PM / 22 days ago

BRIEF-Myovant Sciences To Present New Data On Relugolix In Prostate Cancer At ASCO

May 14 (Reuters) - Myovant Sciences Ltd:

* MYOVANT SCIENCES TO PRESENT NEW DATA ON RELUGOLIX IN PROSTATE CANCER AT AMERICAN SOCIETY OF CLINICAL ONCOLOGY (ASCO) 2020 ANNUAL MEETING Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below